Discover
XENE
Xenon Pharmaceuticals Inc.
63.92
1 x 63.88
1 x 63.94
bid
ask
-
0.31
0.49%
01:34 PM
timesize
| Ytd | 42.61% | |
| 1y | 87.39% |
63.45
day range
64.55
35.10
52 week range
72.66
| Open | 64.32 | Prev Close | 64.23 | Low | 63.45 | High | 64.55 | Mkt Cap | 6.18B |
| Vol | 317.98K | Avg Vol | 1.35M | EPS | -4.70 | P/E | -13.61 | Forward P/E | -12.87 |
| Beta | 0.62 | Short Ratio | 3.26 | Inst. Own | 109.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 60.34 | 200-d Avg | 50.79 | 1yr Est | 81.35 |
| Income Statement | |||
| Operating Expenses | 123.16M | ||
| Research and Development Expense | 99.22M | ||
| Selling, General and Administrative Expense | 23.93M | ||
| Operating Income | -123.15M | ||
| Income Tax Expense | -585.00K | ||
| Net Income | -110.74M | ||
| Net Income Common Stock | -110.74M | ||
| Net Income Common Stock (USD) | -110.74M | ||
| Consolidated Income | -110.74M | ||
| Earnings per Basic Share | -1.11 | ||
| Earnings per Basic Share (USD) | -1.11 | ||
| Earnings per Diluted Share | -1.11 | ||
| Earning Before Interest & Taxes (EBIT) | -111.32M | ||
| Earning Before Interest & Taxes (USD) | -111.32M | ||
| Weighted Average Shares | 99.61M | ||
| Weighted Average Shares Diluted | 99.61M | ||
| Balance Sheet | |||
| Cash and Equivalents | 119.53M | ||
| Cash and Equivalents (USD) | 119.53M | ||
| Investments | 1.13B | ||
| Investments Current | 811.16M | ||
| Investments Non-Current | 314.41M | ||
| Trade and Non-Trade Receivables | 1.63M | ||
| Current Assets | 945.87M | ||
| Property, Plant & Equipment Net | 13.16M | ||
| Total Assets | 1.30B | ||
| Debt Current | 1.34M | ||
| Total Debt | 6.42M | ||
| Current Liabilities | 45.01M | ||
| Debt Non-Current | 5.08M | ||
| Total Liabilities | 53.38M | ||
| Accumulated Retained Earnings (Deficit) | -1.46B | ||
| Accumulated Other Comprehensive Income | -2.66M | ||
| Shareholders Equity | 1.24B | ||
| Shareholders Equity (USD) | 1.24B | ||
| Assets Non-Current | 349.90M | ||
| Total Debt (USD) | 6.42M | ||
| Liabilities Non-Current | 8.37M | ||
| Trade and Non-Trade Payables | 43.67M | ||
| Tax Assets | 14.36M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 883.00K | ||
| Net Cash Flow from Financing | 26.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -426.34M | ||
| Capital Expenditure | -275.00K | ||
| Issuance (Purchase) of Equity Shares | 26.00K | ||
| Net Cash Flow from Investing | -331.24M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -330.96M | ||
| Net Cash Flow from Operations | -95.39M | ||
| Effect of Exchange Rate Changes on Cash | 262.00K | ||
| Share Based Compensation | 16.73M | ||